SZ reimburses costs for COVID treatment

Writer: Zhang Yu  |  Editor: Liu Minxia  |  From: Shenzhen Daily  |  Updated: 2023-01-18

The hospitalization costs for COVID-19 patients will continue to be fully reimbursed until the end of March, according to the city’s health-care security bureau.

Costs of over 700 kinds of medicines, including Paxlovid, Azvudine and Molnupiravir, can get 85% reimbursed during the period, the bureau said.

The costs will be shared between several State-run health-care plans — such as the country’s basic medical insurance and the insurance for severe illnesses — and local finance authorities.

For COVID patients who use medicines covered by the basic medical insurance other than those listed in the provincial outpatient medication catalogue for COVID treatment, the costs are reimbursed according to the city’s regular medical insurance policy.

The medical expenses related to COVID infections generated by the insured patients’ first diagnosis on internet hospitals can also be paid and reimbursed online, and the reimbursement standard is the same as offline costs.

The costs for follow-up consultation services for COVID symptoms on internet hospitals are reimbursed in line with the current reimbursement policy.